Planning and core analyses for periodic aggregate safety data reviews
Authors:
- 26 January 2011
- journal article
- review article
- Published by SAGE Publications in Clinical Trials
- Vol. 8 (2) , 175-182
Abstract
Background In 2009, the Safety Planning, Evaluation and Reporting Team gave detailed recommendations for a well-planned and systematic approach for safety data collection and analysis. Important aspects of this approach included regular reviews of aggregate data by a multidisciplinary team focusing on safety.Keywords
This publication has 5 references indexed in Scilit:
- Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting teamClinical Trials, 2009
- Data Mining and Statistically Guided Clinical Review of Adverse Event Data in Clinical TrialsJournal of Biopharmaceutical Statistics, 2009
- Graphical approaches to the analysis of safety data from clinical trialsPharmaceutical Statistics, 2008
- Accounting for Multiplicities in Assessing Drug Safety: A Three‐Level Hierarchical Mixture ModelBiometrics, 2004
- Forest plots: trying to see the wood and the treesBMJ, 2001